scholarly journals A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m2for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

2012 ◽  
Vol 10 (11) ◽  
pp. 1391-1398 ◽  
Author(s):  
Matthew G. Fury ◽  
Eric Sherman ◽  
Donna Lisa ◽  
Neeraj Agarwal ◽  
Kenneth Algazy ◽  
...  
2017 ◽  
Vol 22 (7) ◽  
pp. 782 ◽  
Author(s):  
Marco Siano ◽  
Francesca Molinari ◽  
Vittoria Martin ◽  
Nicolas Mach ◽  
Martin Früh ◽  
...  

Cancer ◽  
1990 ◽  
Vol 66 (4) ◽  
pp. 640-644 ◽  
Author(s):  
Eduardo Tellez-Bernal ◽  
Gonzalo Recondo ◽  
Thierry Guillot ◽  
Mohamed Benhamed ◽  
Christian Domenge ◽  
...  

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 6071-6071 ◽  
Author(s):  
P. Savvides ◽  
J. Greskovich ◽  
J. A. Bokar ◽  
A. Narayan ◽  
W. van Heeckeren ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document